Iridex (IRIX) Research & Development (2010 - 2026)

Iridex has reported Research & Development for 17 years, with the latest figure at $2.5 million in Q3 2026.

• On a quarterly basis, Research & Development changed 0.47% year-over-year to $2.5 million in Q3 2026; TTM through Jul 2026 was $10.5 million, a 1.53% increase from a year earlier, with the FY2026 full-year figure at $10.4 million, down 17.35% from the prior year.
• Research & Development was $2.5 million for Q3 2026 at Iridex, roughly flat from $2.5 million in the prior quarter.
• The five-year high for Research & Development was $5.8 million in Q1 2022, with the low at $2.5 million in Q1 2025.
• Average Research & Development over 5 years is $3.6 million, with a median of $3.7 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Research & Development jumped 44.2% in 2022, then tumbled 34.53% in 2025.
• Over 5 years, Research & Development stood at $4.8 million in 2022, then declined by 19.87% to $3.9 million in 2023, then plunged by 30.18% to $2.7 million in 2024, then fell by 1.59% to $2.7 million in 2025, then slipped by 4.14% to $2.5 million in 2026.
• The last three Research & Development figures came in at $2.5 million (Q3 2026), $2.5 million (Q2 2026), and $2.8 million (Q1 2026), per Business Quant data.